L.J. Altfest & Co’s DexCom DXCM Stock Holding History

L.J. Altfest & Co’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,028	Closed	-$352K	–	343
2025 Q2	$352K	Buy	+4,028	New	+$316K	0.04%	265

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

L.J. Altfest & Co's DXCM Position: Q3 2025 in Review

L.J. Altfest & Co sold out of DexCom (DXCM) in Q3 2025, closing a stake of 4,028 shares — an estimated $352K sold.

L.J. Altfest & Co first reported a position in DXCM in Q2 2025 and held it in 1 quarter. The position peaked at $352K in Q2 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

L.J. Altfest & Co reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
L.J. Altfest & Co sold 4,028 DexCom shares in Q3 2025, an estimated $352K.
L.J. Altfest & Co first reported a position in DexCom in Q2 2025 and held it in 1 quarter.
L.J. Altfest & Co's DexCom position peaked at $352K in Q2 2025.
911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on L.J. Altfest & Co's 13F filing for Q3 2025, filed 21 Oct 2025.